文献速递介入泌尿生殖外周血管DSACT

经桡动脉入路行肾动脉栓塞术的可行性与安全性:单中心前瞻性研究

Feasibility and Safety of Transradial Access for Renal Artery Embolization: A Single Center Prospective Study.
PubMed 文献 · Korean J Radiol · 2025-01-01

本前瞻性单中心研究纳入50例肾血管平滑肌脂肪瘤(46例)或肾出血(4例)患者,评估经桡动脉入路行肾动脉栓塞术的可行性与安全性。技术成功率98%(49/50),临床成功率96%(48/50),无重大不良事件。术后24小时内EQ-5D-5L评分为0.90(95%CI 0.86-0.95),首次随访为0.89(95%CI 0.85-0.92),P=0.332。结论认为经桡动脉入路行肾动脉栓塞术可行且安全,可能作为经股动脉入路的可行替代方案。

要点

  • 肾血管平滑肌脂肪瘤或肾出血患者经桡动脉入路行肾动脉栓塞术技术成功率98%(49/50),临床成功率96%(48/50)。
  • 未发生经桡动脉入路失败、转为经股动脉入路或止血失败的情况。
  • 随访期间无与栓塞术相关的重大不良事件,2例无症状桡动脉闭塞,1例无症状肾动脉部分血栓形成。

核心结论

  • 经桡动脉入路行肾动脉栓塞术在肾血管平滑肌脂肪瘤或肾出血患者中可行且安全,健康相关生活质量高,可能作为经股动脉入路的可行替代方案。

研究设计与样本

  • 前瞻性单中心研究,纳入2020年11月至2024年1月间接受肾动脉栓塞术的50例患者(年龄51±12岁;男11例、女39例),其中肾血管平滑肌脂肪瘤46例、肾出血4例;排除Barbeau D型波形或桡动脉直径<1.5 mm的患者;技术成功在肾血管平滑肌脂肪瘤患者中定义为选择性插管责任动脉并栓塞致血流停滞,在肾出血患者中定义为选择性插管责任动脉并栓塞后无出血证据。

诊断标准与关键数值

  • 肾血管平滑肌脂肪瘤患者技术成功定义为选择性插管责任动脉并栓塞致血流停滞;肾出血患者技术成功定义为选择性插管责任动脉并栓塞后无出血证据;临床成功定义为随访CT示血管平滑肌脂肪瘤缩小且无出血征象、无需额外肾动脉栓塞术。

临床应用与阅片要点

  • 原文结论认为经桡动脉入路行肾动脉栓塞术可行且安全,可能作为经股动脉入路的可行替代方案;术后24小时内EQ-5D-5L评分为0.90(95%CI 0.86-0.95),首次随访为0.89(95%CI 0.85-0.92),P=0.332。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of this study is to evaluate the feasibility and safety of renal artery embolization (RAE) via transradial access (TRA) in patients with renal angiomyolipoma (AML) or renal hemorrhage.

MATERIALS AND METHODS: Data were collected for this prospective single-center study from 50 patients (51 ± 12 years; male:female, 11:39) who underwent RAE for renal AML (n = 46) or renal hemorrhage (n = 4) between November 2020 and January 2024. Patients with a Barbeau D waveform or a radial artery diameter of <1.5 mm were excluded. Technical success in patients with renal AML and renal hemorrhage was defined as achieving selective catheterization of the culprit artery with embolization, leading to flow stasis and the absence of bleeding evidence, respectively. Clinical success was indicated by a reduction in AML size on follow-up CT scans and the absence of bleeding signs without necessitating additional RAE. The EuroQol 5-Dimension 5-level (EQ-5D-5L) questionnaire was utilized to assess health-related quality of life (HRQoL).

RESULTS: In one patient with AML, embolization could not be performed following selective catheterization and angiography due to the lack of visible tumor vascularity, resulting in a technical success rate of 98% (49/50). The clinical success rate was 96% (48/50 patients). No instances of TRA failure, conversion to transfemoral access (TFA), or hemostasis failure were noted. During the follow-up period, no major adverse events associated with the RAE occurred. Two patients exhibited asymptomatic radial artery occlusion, and one patient displayed asymptomatic partial thrombosis of the renal artery at the first follow-up visit. The EQ-5D-5L scores were 0.90 (95% confidence interval [CI]: 0.86-0.95) within 24 hours post-procedure and 0.89 (95% CI: 0.85-0.92) at the first follow-up (P = 0.332).

CONCLUSION: TRA is a feasible and safe approach for performing RAE in patients with renal AML or hemorrhage. RAE performed using TRA demonstrated high HRQoL outcomes and may serve as a viable alternative to TFA for performing RAE.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim J, Chu HH, Jung KH, et al. Feasibility and Safety of Transradial Access for Renal Artery Embolization: A Single Center Prospective Study. Korean J Radiol. 2025. PMID: 40150923. doi:10.3348/kjr.2024.1324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。